Investing in Aura Minerals (TSE:ORA) five years ago would have delivered you a 822% gain
Long term investing can be life changing when you buy and hold the truly great businesses. While not every stock performs well, when investors win, they can win big. Just think about the savvy investors who held Aura Minerals Inc. (TSE:ORA) shares for the last five years, while they gained 604%. This just goes to show the value creation that some businesses can achieve. In the last week the share price is up 2.2%. It really delights us to see such great share price performance for investors.
So let's investigate and see if the longer term performance of the company has been in line with the underlying business' progress.
See our latest analysis for Aura Minerals
While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.
Aura Minerals' earnings per share are down 20% per year, despite strong share price performance over five years.
This means it's unlikely the market is judging the company based on earnings growth. Since the change in EPS doesn't seem to correlate with the change in share price, it's worth taking a look at other metrics.
There's no sign of growing dividends, which might have explained the resilient share price. But it's reasonably likely that the 14% annual compound revenue growth is considered evidence that Aura Minerals has plenty of growth ahead of it. In that case, the company may be sacrificing current earnings per share to drive growth.
The company's revenue and earnings (over time) are depicted in the image below (click to see the exact numbers).
Balance sheet strength is crucial. It might be well worthwhile taking a look at our free report on how its financial position has changed over time.
It is important to consider the total shareholder return, as well as the share price return, for any given stock. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. As it happens, Aura Minerals' TSR for the last 5 years was 822%, which exceeds the share price return mentioned earlier. And there's no prize for guessing that the dividend payments largely explain the divergence!
It's nice to see that Aura Minerals shareholders have received a total shareholder return of 121% over the last year. That's including the dividend. Since the one-year TSR is better than the five-year TSR (the latter coming in at 56% per year), it would seem that the stock's performance has improved in recent times. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Consider for instance, the ever-present spectre of investment risk. We've identified 3 warning signs with Aura Minerals , and understanding them should be part of your investment process.
If you are like me, then you will not want to miss this free list of undervalued small caps that insiders are buying.
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Canadian exchanges.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 hours ago
- Yahoo
Ginkgo MIC Strengthens Investor Resilience Amid Global Pressures and Reaffirms Confidence with Top-Tier Analyst Rating in Mid-Year Market Update
TORONTO, ON AND VANCOUVER, BC / / June 10, 2025 / Ginkgo Mortgage Investment Corporation ("Ginkgo MIC") recently hosted its virtual Mid-Year Market Update, providing valued investors with timely insights into the fund's performance and strategic direction amid ongoing global trade tensions and economic uncertainty. In keeping with its commitment to open communication, Ginkgo's leadership addressed current market realities-including inflationary pressures, rising unemployment, and continued volatility in the Canadian housing market. As of February 2025, Ginkgo MIC's total assets have grown by 8% to $187 million, while the portfolio's average loan-to-value (LTV) ratio has been further reduced to 66%. The percentage of loans delinquent over 90 days has remained stable at 3.56%, supported by disciplined lending practices, tighter underwriting standards, and a renewed focus on borrower quality and cash flow. To further insulate the fund against market volatility, Ginkgo plans to increase its bad debt provisions to $2 million, reinforcing its ability to maintain stable distributions even in a shifting economic environment. "Our team anticipated that 2025 would be a challenging year, as shared during our February AGM," said Henry Tse, CEO of Ginkgo MIC. "Despite seven interest rate cuts by the Bank of Canada, the housing market remains subdued, and broader economic uncertainty continues to grow." Up to this point, Ginkgo has maintained its annual dividend rates at 9.75% for Series 1 and 9.0% for Series 2 Preferred Shares. "To support long-term portfolio stability and to compete more effectively in the market, it is time to further strengthen our financial position," Tse added. As a result, effective July 2025, Ginkgo's Board has revised its target dividends to 9.25% for Series 1 and 8.5% for Series 2 Preferred Shares. These rates remain highly competitive and reflect Ginkgo's focus on balancing attractive yields with prudent capital preservation. Demonstrating external confidence in Ginkgo's strategy, Fundamental Research Corp (FRC) recently upgraded Ginkgo MIC to a 2+ rating-one of the highest in the industry based on FRC's latest annual review. This upgrade highlights Ginkgo's consistent dividend history, strong governance practices, and commitment to transparency. To access the full FRC analysis, please click here: Read the 2025 FRC Report Ginkgo MIC remains focused on protecting investor capital and adapting its strategies to meet the realities of today's evolving market. For more information about this news release or Ginkgo MIC's fund performance, please visit email investor@ or contact Yvonne Leung at 416-990-5567. About The Corporation: Ginkgo Mortgage Investment Corporation was founded in 2011 and serves across Canada as an alternative lender. The MIC provides dividends to investors through a diversified portfolio that is secured by properties primarily in the Greater Toronto Area (GTA), Greater Vancouver Area (GVA), Alberta (Edmonton and Calgary) and the Winnipeg communities. Since inception, Ginkgo has paid over $60 million dividends to investors. Legal Disclaimers This press release is intended for information purposes only and does not constitute an offer to sell or a solicitation to buy securities. No securities regulatory authority or regulator has assessed the merits of the information herein or reviewed this press release. Further, the contents of this press release should be read in conjunction with Ginkgo's offering memorandum dated November 30, 2023, as amended from time to time, a copy of which can be made available to you by contacting us. Past Performance; No Guarantees Past performance is not a guarantee of future results and readers should not assume that the future performance of Ginkgo will equal or better Ginkgo's historical performance. Target yields with respect to Ginkgo's preference shares are merely targets determined from time to time by the Board of Directors in its sole discretion based on several factors including but not limited to the general economic conditions, local real estate markets and prevailing levels of interest rates. The payment of dividends is subject to the discretion of the Board of Directors to establish working capital and other reserves for Ginkgo. Readers should not confuse Ginkgo's target yields with Ginkgo's rate of return or yield. There is no guarantee that Ginkgo will be able to pay dividends at the levels targeted. The amount of dividends declared may fluctuate from time to time and there can be no assurance that Ginkgo will declare any dividends in any particular month or months or that Ginkgo will declare a special dividend in for the same amount or at all in subsequent fiscal periods. Forward-Looking Statements Certain statements provided in this press release, to the extent that they relate to Ginkgo and its views or predictions about possible events, conditions or results of operations that are based on assumptions about future economic conditions and courses of action and includes future-oriented financial information with respect to prospective results of operations, financial position or cash flows that is presented either as a forecast or projection, may be "forward-looking statements" within the meaning of that phrase under applicable Canadian securities laws. Although Ginkgo believes that expectations reflected in any forward-looking statements provided in this press release are reasonable, it cannot guarantee future results, levels of activity, performance or achievements. Forward-looking statements are based on the current expectations, estimates and projections of Ginkgo, and involve a number of known and unknown risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. The forward-looking statements herein are made as of the date they are provided in this press release. Except as otherwise required by law, Ginkgo does not intend to, and assumes no obligation to, update or revise any forward-looking statements it may provide in this press release, whether because of new information, plans or events or otherwise. Readers are cautioned not to place undue reliance on any forward-looking statements in this press release as there can be no assurance that the conditions, events, plans and assumptions on which they are based will occur. SOURCE: Ginkgo Mortgage Investment Corporation View the original press release on ACCESS Newswire Sign in to access your portfolio
Yahoo
21 hours ago
- Yahoo
Asian Value Stocks Estimated Below Intrinsic Worth
As global markets navigate a complex landscape, the Asian financial scene is drawing attention with its potential for value investing, particularly as China's economic indicators suggest room for further stimulus and Japan's moderate recovery continues. In this environment, identifying stocks that are trading below their intrinsic worth can be an effective strategy, offering opportunities to capitalize on market inefficiencies while mitigating risk through thorough analysis. Name Current Price Fair Value (Est) Discount (Est) Wenzhou Yihua Connector (SZSE:002897) CN¥38.99 CN¥76.64 49.1% Taiyo Yuden (TSE:6976) ¥2411.50 ¥4741.52 49.1% Livero (TSE:9245) ¥1692.00 ¥3352.54 49.5% Kanto Denka Kogyo (TSE:4047) ¥841.00 ¥1677.13 49.9% Hangzhou Zhongtai Cryogenic Technology (SZSE:300435) CN¥16.67 CN¥33.21 49.8% Gushengtang Holdings (SEHK:2273) HK$38.35 HK$76.50 49.9% Fuji (TSE:6134) ¥2253.50 ¥4448.27 49.3% Everest Medicines (SEHK:1952) HK$54.55 HK$107.01 49% Brangista (TSE:6176) ¥597.00 ¥1180.86 49.4% Boditech Med (KOSDAQ:A206640) ₩15850.00 ₩31439.92 49.6% Click here to see the full list of 302 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Below we spotlight a couple of our favorites from our exclusive screener. Overview: Yuhan Corporation is a South Korean company that manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods both domestically and internationally, with a market cap of ₩8.04 trillion. Operations: The company's revenue segments include biotechnology startups, which contribute ₩2.11 billion to its overall earnings. Estimated Discount To Fair Value: 22.4% Yuhan's current trading price of ₩107,300 is significantly below its estimated fair value of ₩138,269.28, suggesting it may be undervalued based on cash flows. Despite a forecasted 44% annual earnings growth outpacing the Korean market average, recent financials show declining profit margins and net income compared to the previous year. The company has engaged in substantial share buybacks over time but reported no repurchases in early 2025. Our comprehensive growth report raises the possibility that Yuhan is poised for substantial financial growth. Click here and access our complete balance sheet health report to understand the dynamics of Yuhan. Overview: ASMPT Limited is an investment holding company that designs, manufactures, and markets machines, tools, and materials for the semiconductor and electronics assembly industries globally, with a market cap of HK$23.74 billion. Operations: The company's revenue is primarily derived from its Semiconductor Solutions segment, which generated HK$7.42 billion, and its Surface Mount Technology (SMT) Solutions segment, contributing HK$5.79 billion. Estimated Discount To Fair Value: 41.9% ASMPT's current trading price of HK$57 is significantly below its estimated fair value of HK$98.04, highlighting potential undervaluation based on cash flows. Despite a decrease in profit margins and net income compared to the previous year, ASMPT anticipates revenue growth between US$410 million and US$470 million for Q2 2025, driven by seasonal factors and strong bookings. The company declared a special dividend of HKD 0.25 per share but reduced its final dividend to HKD 0.07 per share for 2024. The analysis detailed in our ASMPT growth report hints at robust future financial performance. Get an in-depth perspective on ASMPT's balance sheet by reading our health report here. Overview: Accton Technology Corporation is engaged in the research, development, manufacturing, and sale of network communication equipment across Taiwan, America, Asia, Europe, and other international markets with a market cap of NT$411.92 billion. Operations: The company's revenue primarily comes from its Computer Networks segment, which generated NT$134.33 billion. Estimated Discount To Fair Value: 33.9% Accton Technology's current trading price of NT$737 is substantially below its estimated fair value of NT$1115.68, suggesting undervaluation based on cash flows. The company reported significant earnings growth for Q1 2025, with net income rising to TWD 5.13 billion from TWD 2.24 billion a year earlier. Despite high non-cash earnings, Accton's projected revenue and profit growth rates exceed Taiwan's market averages, indicating robust future performance potential despite moderate annual profit growth forecasts. Our earnings growth report unveils the potential for significant increases in Accton Technology's future results. Click to explore a detailed breakdown of our findings in Accton Technology's balance sheet health report. Access the full spectrum of 302 Undervalued Asian Stocks Based On Cash Flows by clicking on this link. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include KOSE:A000100 SEHK:522 and TWSE:2345. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21 hours ago
- Yahoo
Asian Dividend Stocks To Watch In 2023
As global markets navigate a complex landscape of trade tensions and economic shifts, Asian indices have shown resilience, with Chinese stocks gaining momentum amid expectations of government stimulus. In this environment, dividend stocks in Asia present an intriguing opportunity for investors seeking steady income streams, particularly as companies with strong fundamentals and reliable payout histories can offer stability amidst market fluctuations. Name Dividend Yield Dividend Rating Yamato Kogyo (TSE:5444) 4.44% ★★★★★★ Wuliangye YibinLtd (SZSE:000858) 5.07% ★★★★★★ Nissan Chemical (TSE:4021) 4.20% ★★★★★★ Japan Excellent (TSE:8987) 4.39% ★★★★★★ HUAYU Automotive Systems (SHSE:600741) 4.50% ★★★★★★ Guangxi LiuYao Group (SHSE:603368) 4.42% ★★★★★★ DoshishaLtd (TSE:7483) 4.18% ★★★★★★ Daicel (TSE:4202) 5.01% ★★★★★★ CAC Holdings (TSE:4725) 4.87% ★★★★★★ Asian Terminals (PSE:ATI) 6.37% ★★★★★★ Click here to see the full list of 1240 stocks from our Top Asian Dividend Stocks screener. Here's a peek at a few of the choices from the screener. Simply Wall St Dividend Rating: ★★★★☆☆ Overview: GS Holdings Corp., along with its subsidiaries, operates in the energy, power generation, retail, service, construction, and infrastructure sectors with a market cap of ₩4.49 trillion. Operations: GS Holdings Corp.'s revenue primarily comes from its Distribution segment at ₩11.39 trillion, followed by the Gas and Electric Business at ₩7.43 trillion, Trade at ₩3.91 trillion, with an adjustment for Cross-Sector Revenue of -₩0.21 trillion. Dividend Yield: 5.7% GS Holdings offers a compelling dividend profile with its payouts well-covered by earnings (63.7% payout ratio) and cash flows (47.4% cash payout ratio). The dividend yield of 5.68% ranks in the top 25% of South Korean market payers, though the company has only a three-year history of dividends, indicating limited track record stability. Despite recent profit margin declines, GS Holdings trades at a significant discount to fair value estimates and peers, enhancing its attractiveness as a value investment. Take a closer look at GS Holdings' potential here in our dividend report. Our valuation report here indicates GS Holdings may be undervalued. Simply Wall St Dividend Rating: ★★★★☆☆ Overview: Shandong Weigao Group Medical Polymer Company Limited is involved in the R&D, production, wholesale, and sale of medical devices both in China and internationally, with a market cap of HK$26.97 billion. Operations: Shandong Weigao Group Medical Polymer's revenue is primarily derived from its Medical Device Products segment at CN¥6.60 billion, followed by Interventional Products at CN¥1.98 billion, Pharma Packaging Products at CN¥2.28 billion, Orthopaedic Products at CN¥1.44 billion, and Blood Management Products at CN¥876.78 million. Dividend Yield: 4% Shandong Weigao Group Medical Polymer provides a mixed dividend profile, with payouts covered by earnings (47.3% payout ratio) and cash flows (45.9% cash payout ratio), yet its dividend history has been volatile over the past decade. Recent shareholder-approved buybacks aim to enhance net asset value and earnings per share, potentially bolstering future dividends. The company trades at a considerable discount to fair value estimates, though its current yield of 3.98% lags behind top-tier payers in Hong Kong. Click here and access our complete dividend analysis report to understand the dynamics of Shandong Weigao Group Medical Polymer. Our valuation report unveils the possibility Shandong Weigao Group Medical Polymer's shares may be trading at a discount. Simply Wall St Dividend Rating: ★★★★☆☆ Overview: Dongfang Electric Corporation Limited designs, develops, manufactures, and sells power generation equipment in China and internationally with a market cap of HK$60.10 billion. Operations: Dongfang Electric Corporation Limited's revenue segments include CN¥45.23 billion from thermal power equipment, CN¥12.78 billion from hydropower equipment, CN¥5.67 billion from wind power equipment, and CN¥3.45 billion from nuclear power equipment. Dividend Yield: 3.6% Dongfang Electric's dividends are supported by earnings (43.1% payout ratio) and cash flows (59.2% cash payout ratio), though its dividend history has been unstable over the last decade. Recent earnings reports show improved financial performance, with Q1 2025 net income rising to CNY 1.15 billion from CNY 905.75 million a year earlier, yet the proposed final dividend for 2024 decreased, reflecting ongoing volatility in payouts despite potential growth prospects. Get an in-depth perspective on Dongfang Electric's performance by reading our dividend report here. The valuation report we've compiled suggests that Dongfang Electric's current price could be inflated. Take a closer look at our Top Asian Dividend Stocks list of 1240 companies by clicking here. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include KOSE:A078930 SEHK:1066 and SEHK:1072. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
